Author:
Ban Yoshiki,Sato Takahiro,Nakatsuka Toshio,Kemi Masayuki,Samura Keiji,Matsumoto Hiroyoshi,Cukierski Mark A,van Zwieten Matthew J
Reference37 articles.
1. Hardman J, Limbird LE, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. New York: McGraw-Hill, 1996.
2. Selective muscarinic receptor agonists and antagonists;Eglen;Pharmacol. Toxicol.,1996
3. Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel muscarinic antagonist with M2-sparing antagonistic activity;Hirose;J. Pharmacol. Exp. Ther.,2001
4. A potent, long-acting, orally active (2R)-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors;Mitsuya;J. Med. Chem.,2000
5. Evaluation of reproductive toxicity by testicular sperm head counts;Meistrich;J. Am. Coll. Tox.,1989
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献